Radioimmunotherapy (RIT) is a method by which radiation (radionuclide) is selectively delivered to its target by means of monoclonal antibodies, usually of mouse origin. Repetition of the treatment may improve response rates, but is limited by the development of human anti-mouse antibodies (HAMA), which are detectable in up to 50% of patients after a single injection 1, 2 . The presence of HAMA in the serum leads to immune complex formation on reexposure to the mouse antibody, with rapid clearance of the complex through liver and spleen and the risk of acute hypersensitivity reactions. Immunosuppression with cyclosporin can delay the production of HAMA 1,3 , and plasmapheresis has been used to reduce HAMA titres suf®ciently to allow further RIT 4 .
CASE HISTORY
A man aged 62 with liver metastases from a previously resected rectal carcinoma was treated with two courses of RIT. He had no history of atopy. The antibody used was F(ab') 2 fragment of the monoclonal anticarcinoembryonic antibody-A5B7 5 . 100 mCi of 131 I-labelled antibody (10 mg) was given intravenously in 25 minutes. Radioiodination was performed by the N-bromosuccinide method 6 . Concomitant oral cyclosporin was administered to prevent HAMA formation (serum levels 213±577 mg/L). A complete response, lasting 5 weeks, was seen after the ®rst course of treatment and overall he had a partial response by World Health Organization criteria after two cycles of RIT. No further RIT was given because of the development of HAMA, detected by an enzyme immunoassay 1 . Seven months later he relapsed with rising tumour markers and enlarging liver metastases which proved unresponsive to chemotherapy with folinic acid and 5-¯uorouracil. Ten months after this relapse, to allow further RIT, he underwent plasma exchange on two consecutive days before antibody administration. On both days three litres of plasma was replaced by three litres of human albumin 4.5% containing 10% calcium gluconate. Afterwards no HAMA IgG was detected in the patient's serum by enzyme immunoassay in triplicate ( Figure 1 ) and a skin test was negative. An infusion of 131 I-A5B7 F(ab') 2 was then started but after ®ve minutes the patient became acutely hypotensive with tachycardia followed by cardiac collapse. The infusion was stopped immediately and he was successfully resuscitated.
To investigate the probable cause of this reaction, serum before and after plasmapheresis was analyzed to identify immune complexes by use of S-300 column chromatography (Pharmacia, St Albans, UK) 3 . Figure 2 shows a single peak at a higher molecular weight than the free F(ab') 2 , con®rming the presence of a complex between the F(ab') 2 antibody and HAMA in the patient's serum taken before plasmapheresis. After plasmapheresis the elution pro®le of the incubated serum shows two peaks at different molecular weights ( Figure 2 ). The smaller peak at the lower molecular weight is equivalent to free F(ab') 2 and the larger peak at the higher molecular weight suggests the presence of an immune complex.
COMMENT
How can we account for this patient's anaphylactic reaction when enzyme immunoassay after plasmapheresis detected no HAMA IgG in his serum? The S-300 pro®le of the serum after plasmapheresis demonstrated free F(ab') 2 and a second peak of higher molecular weight indicating that the F(ab') 2 was complexing with the patient's serum. This complex was unlikely to be due to binding of the F(ab') 2 antibody to circulating carcinoembryonic antigen in the serum since these levels were low (5100 mg/L). In addition, the molecular weight of the immune complex was too low for it to be an IgM molecule in the patient's serum. We therefore postulate that this could be an IgE antibody in the absence of IgG. The serum IgE before plasmapheresis was 628 kIU/L, falling to 320 kIU/L after treatment (normal 5120 kIU/L) and at this time the skin test was negative. 24 hours after RIT the serum IgG had risen to 799 kIU/L. These results suggest that plasmapheresis does not completely remove IgE, and the residual IgE may have caused the hypersensitivity reaction. A second mechanism for immune complex formation may have been rapid generation of anti-mouse IgG antibodies produced by circulating memory cells.
We conclude that plasmapheresis cannot be relied upon to remove all HAMA after RIT, and that column chromatography can identify immune complexes undetectable by immunoassay. This test may be useful in identifying those patients at risk from hypersensitivity reactions when RIT is repeated. Before plasmapheresis (^); after plasmapheresis (~). The third curve (.) demonstrates the elution pro®le of 131 I-F(ab') 2 antibody incubated with serum of a patient without HAMA
